Skip to main content

Published locations for Moderate-to-severe atopic dermatitis: Astegolimab fails to reduce disease severity in phase 2 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Moderate-to-severe atopic dermatitis: Astegolimab fails to reduce disease severity in phase 2 trial

User login

  • Reset your password
  • /content/moderate-severe-atopic-dermatitis-astegolimab-fails-reduce-disease-severity-phase-2-trial
  • /dermatology/article/258033/atopic-dermatitis/moderate-severe-atopic-dermatitis-astegolimab-fails